Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:287-291

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masters, R. G.
Right arrow Articles by de Bold, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masters, R. G.
Right arrow Articles by de Bold, A. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
Related Collections
Right arrow Other diagnostic testing
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 1999;100:287-291.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Discoordinate Modulation of Natriuretic Peptides During Acute Cardiac Allograft Rejection in Humans

Roy G. Masters, MD; Ross A. Davies, MD; John P. Veinot, MD; Paul J. Hendry, MD; Stuart J. Smith, MD; Adolfo J. de Bold, PhD

From the Departments of Surgery (R.G.D., P.J.H.), Medicine (R.A.D., S.J.S.), and Pathology and Laboratory Medicine (J.P.V., A.J.d.B.), University of Ottawa, the Ottawa Heart Institute, and the Ottawa Hospital Civic Site, Ottawa, Ontario, Canada.

Correspondence to Dr Adolfo J. de Bold, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario K1Y 4W7, Canada. E-mail adebold{at}ottawaheart.ca

Background—Increased circulating levels of the cardiac polypeptide hormones atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) may be observed after orthotopic cardiac transplantation. Both the hypertrophic and inflammatory processes in the allograft may contribute to this increase, but no mechanistic explanation has been suggested for this observation.

Methods and Results—Plasma immunoreactive ANF and BNP determinations were performed in 10 consecutive transplant patients. These were correlated with degree of rejection as reflected by histopathological findings at serial endomyocardial biopsies. Three patients had associated hemodynamic measurements and blood samples 24 hours before and after transplantation. All rejection episodes that received treatment were accompanied by a marked increase in BNP plasma levels to >{approx}400 pg/mL. Steadily increasing BNP levels preceded overt rejection as assessed by histopathological criteria. The increase in plasma BNP was not always accompanied by an increase in ANF, which suggests the specific upregulation of BNP gene expression during acute rejection episodes. Treatment of the acute rejection episodes led to a substantial decrease of BNP plasma levels.

Conclusions—The significant selective increase in plasma BNP levels found in the present study has not been previously described. This finding provides a new insight into the mechanism of allograft rejection and the modulation of natriuretic peptide synthesis and release. Furthermore, although preliminary, the data suggest that BNP plasma levels could form the basis for a new, noninvasive screening test to predict acute cardiac allograft rejection. Because treatment with the antilymphocyte monoclonal antibody OKT3 (murine monoclonal antibody to the CD3 antigen of the human T-cell) decreased BNP plasma levels, cytokine production by T-cells may mediate the selective increase in circulating BNP.


Key Words: transplantation • natriuretic peptides • atrial natriuretic factor • myocarditis • pathology




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ogawa, J. P. Veinot, M. L. Kuroski de Bold, T. Georgalis, and A. J. de Bold
Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2596 - H2603.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
D. Jain, H. B. Gehl, H. A. Katus, and G. Richardt
Penetrating Atherosclerotic Ulcer of the Ascending Aorta: A Delayed Complication of Coronary Artery Bypass Surgery: A Case Report
Angiology, March 1, 2003; 54(2): 251 - 255.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. F. Immer, H. Barmettler, P. A. Berdat, A. S. Immer-Bansi, L. Englberger, E. S. Krahenbuhl, and T. P. Carrel
Effects of deep hypothermic circulatory arrest on outcome after resection of ascending aortic aneurysm
Ann. Thorac. Surg., August 1, 2002; 74(2): 422 - 425.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Erbel, F. Alfonso, C. Boileau, O. Dirsch, B. Eber, A. Haverich, H. Rakowski, J. Struyven, K. Radegran, U. Sechtem, et al.
Diagnosis and management of aortic dissection: Task Force on Aortic Dissection, European Society of Cardiology
Eur. Heart J., September 2, 2001; 22(18): 1642 - 1681.
[PDF]


Home page
Eur Heart JHome page
A.J. Drake-Holland and M.I.M. Noble
Neural-natriuretic hormone interactions
Eur. Heart J., March 2, 2000; 21(6): 424 - 426.
[PDF]